Integer Holdings Acquires Oscor, Inc.

December 2, 2021—Integer Holdings Corporation, a medical device outsource manufacturer, announced the close of its acquisition of Oscor, Inc.

According to Integer, Oscor is a privately held company that employs approximately 900 employees with design, development, and manufacturing operations in Palm Harbor, Florida, and the Dominican Republic, as well as business offices in Germany.

Oscor designs, develops, manufactures, and markets a portfolio of specialized medical devices, venous access systems, diagnostic catheters, and implantable devices. The company offers a complete line of finished introducer systems, guiding sheaths, and lead wire technologies for cardiac pacing, electrophysiology, neurostimulation, cardiovascular, peripheral vascular, and structural heart markets. In addition, the acquisition broadens Integer’s research and development capabilities and expands its manufacturing presence to the Dominican Republic, augmenting Integer’s already extensive global footprint and manufacturing capabilities.

“The acquisition of Oscor strengthens Integer’s ability to serve our customers by expanding our product offering in steerable sheaths and cardiac and neurostimulation leads and adding low-cost manufacturing capacity to support growth,” commented Integer President and CEO Joe Dziedzic in the company’s press release. “The addition of Oscor’s strong brand will deepen our relationships with existing customers, bring new customers to Integer, and allow us to build relationships with several emerging growth companies. We are thrilled to welcome Oscor associates to the Integer team.”

Thomas Osypka, Oscor’s owner, president and CEO, stated, “Since launched by my father, Dr. Peter Osypka, nearly 40 years ago, Oscor has been a pioneer in the field of implantable medical technology and electrophysiology. I am proud of Oscor’s strong record of accomplishments, which the team can now accelerate by uniting with Integer.”